Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Index levels shift due to earnings, valuations, and macro surprises. Knowing the main drivers helps you anticipate potential reversals.
17,383 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Atlassian Corp. PLC posted stronger-than-expected Q1 results, but its stock has still tumbled. With 25 analysts stick...
Texas builders confront a payment-first market as borrowers remember ultra-low rates from 2.65% era. The new calculus...
When geopolitics and supply chains collide, a single stock can surge. This article breaks down why rare earth stock s...
Ethereum recently climbed notably in a short span, prompting questions about whether now is the right moment to buy. ...
The Middle East crisis is sending shockwaves through the stock market, but airlines are taking the biggest hit. This ...
Ripple’s XRP is trading in a tight range while key indicators hint at a potential breakout. Analysts diverge on direc...
A top strategist warns that investor fear could surge as U.S.-Iran tensions persist, with markets facing heightened v...
As inflation lingers and wages stall, a growing share of Americans are turning down weddings, dinners, and gatherings...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
TeraWulf stunned investors with a powerful April rally, rising about 50% as crypto momentum and cost discipline colli...